Yadong Chen
Impact in
-
- Computational Drug Discovery Methods
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 34
- Histone Deacetylase Inhibitors Research 24
- Cancer therapeutics and mechanisms 13
- Ubiquitin and proteasome pathways 12
- Melanoma and MAPK Pathways 11
-
- Computational Drug Discovery Methods 56
- Co-authors
- Tao Lu (58 shared papers)Yanmin Zhang (59 shared papers)Haichun Liu (52 shared papers)Rutao Liu (7 shared papers)Tao Lu (40 shared papers)Shuai Lü (34 shared papers)Qidong You (13 shared papers)Haoliang Yuan (19 shared papers)
- Journals
- European Journal of Medicinal Chemistry (30 papers)Journal of Medicinal Chemistry (18 papers)Journal of Chemical Information and Modeling (16 papers)Molecular Diversity (13 papers)Bioorganic & Medicinal Chemistry (7 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yadong Chen
205 papers receiving 3.4k citations
Yadong Chen's Hit Papers
Peers
Comparison fields: 5 of 150
- Computational Theory and Mathematics 592
- Molecular Biology 1.8k
- Hematology 260
- Organic Chemistry 676
- Oncology 531
Countries citing papers authored by Yadong Chen
This map shows the geographic impact of Yadong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yadong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yadong Chen more than expected).
Fields of papers citing papers by Yadong Chen
This network shows the impact of papers produced by Yadong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yadong Chen. The network helps show where Yadong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yadong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 158 | |
| 2 | Drug repositioning: Progress and challenges in drug discovery for various diseases Hit paper breakdown → | 2022 | 138 |
| 3 | 2018 | 90 | |
| 4 | 2021 | 86 | |
| 5 | 2017 | 73 | |
| 6 | 2019 | 73 | |
| 7 | 2021 | 69 | |
| 8 | 2013 | 64 | |
| 9 | 2019 | 58 | |
| 10 | 2016 | 57 | |
| 11 | 2020 | 56 | |
| 12 | 2019 | 54 | |
| 13 | 2007 | 53 | |
| 14 | 2016 | 52 | |
| 15 | 2018 | 50 | |
| 16 | 2013 | 47 | |
| 17 | 2020 | 43 | |
| 18 | 2008 | 42 | |
| 19 | 2014 | 41 | |
| 20 | 2013 | 40 |
About Yadong Chen
Yadong Chen is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Oncology and Hematology, having authored 214 papers that have together received 3.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (56 papers), Protein Degradation and Inhibitors (34 papers), Histone Deacetylase Inhibitors Research (24 papers), Synthesis and biological activity (16 papers), Click Chemistry and Applications (15 papers), Cancer therapeutics and mechanisms (13 papers), Ubiquitin and proteasome pathways (12 papers) and Melanoma and MAPK Pathways (11 papers). The work is most often cited by research in Computational Theory and Mathematics (592 citations), Molecular Biology (1.8k citations), Hematology (260 citations), Organic Chemistry (676 citations) and Oncology (531 citations). Yadong Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Tao Lu, Yanmin Zhang, Haichun Liu, Rutao Liu, Tao Lu, Shuai Lü, Qidong You, Haoliang Yuan, Rui Zhang and Hongmei Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling, Molecular Diversity and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.